Clinical Trial Update: A 2-Month Safety Follow-Up Trial

View source ↗

Summary

This document reports the completion of a 2-month safety follow-up trial sponsored by MannKind Corporation in individuals with Type 1 diabetes mellitus or Type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 1 Diabetes, Type 2 Diabetes | Status: COMPLETED